Oxford Immunotec Schedules First Quarter 2020 Earnings Release and Conference Call for May 5, 2020

Udgivet den 29-04-2020  |  kl. 13:15  |  

OXFORD, United Kingdom and MARLBOROUGH, Mass., April 29, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the Company), a global, high-growth diagnostics company, today announced that it plans to release first quarter 2020 financial results before the open of the market on Tuesday, May 5, 2020.  Dr. Peter Wrighton-Smith, Chief Executive Officer, and Matt McLaughlin, Chief Financial Officer, will host a conference call to review the Company's financial results at 8:00 a.m. Eastern Time the same day.  The call will be concurrently webcast.

To listen to the conference call on your telephone, please dial (855) 363-5047 for United States callers or +1 (484) 365-2897 for international callers and reference confirmation code 8473556, approximately 15 minutes prior to start time.  To access the live audio webcast or subsequent archived recording, visit the Investor Relations section of Oxford Immunotec's website at www.oxfordimmunotec.com.  The replay will be available on the Company's website for approximately 60 days.

About Oxford Immunotec

Oxford Immunotec Global PLC is a global, high-growth diagnostics company.  We bring energy and invention to a world in need of diagnostic truth.  Our leading product, the T-SPOT®.TB test, is used for diagnosing infection with Tuberculosis, the world's largest cause of death from infectious disease.  The T-SPOT.TB test has been approved for sale in over 60 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China.  The Company is headquartered near Oxford, U.K. and in Marlborough, MA.  Additional information can be found at www.oxfordimmunotec.com.

T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd.

CONTACTS:

For Media and Investor Inquiries:
Matt McLaughlin
Chief Financial Officer
Oxford Immunotec
Tel: +1 (508) 573-9953
mtmclaughlin@oxfordimmunotec.com

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

17:21 Meta Platforms på rekordkurs efter Tiktok står over for amerikansk forbud efter dom
17:06 Fredagens aktier: Pandora var den klareste stjerne og trodsede C25 i marginalt plus
17:00 Fredagens obligationer: Rentefald efter amerikanske jobdata fadede ud
16:01 Amerikansk forbrugertillid stiger - også mere end ventet - i december
15:39 USA/åbning: Grønt boost efter jobtal - regnskaber giver kursplus til Lululemon og HP
15:25 Pandora på rekordkurs efter positiv sektoranalyse fra Goldman Sachs
15:12 Nordnet spår muligt C25-comeback til Netcompany eller FLSmidth
14:57 Økonomer tror fortsat på amerikansk rentesænkning i december efter jobtal
14:54 USA/tendens: Humøret vender på Wall Street - regnskab løfter Lululemon og HP
14:45 Renter dykker og futures går i grønt efter stigende arbejdsløshed i USA
14:34 Amerikansk beskæftigelsesrapport viser højere ledighed end ventet
13:59 USA/tendens: Afventende Wall Street før jobtal - regnskabsnyt løfter Lululemon og HP
13:41 Tidlig julegave fra Danske Bank: Udbetaler udbytte fra salg i Norge
13:26 Softwareselskabet Docusign går grøn dag i møde efter opløftende regnskab
13:16 Europa/middag: Britisk forsikringshandel sender aktie i front i afventende middagshandel
13:06 SP Group dropper produktion i Kvistgård og vil opsige medarbejdere
12:31 Obligationer/middag: Renten stiger frem mod amerikansk jobrapport
12:01 Moncler stiger på frisk købsanbefaling fra Goldman Sachs
11:53 Aktier/middag: Bryggeriaktier i top på afventende dag - Mærsk i mindre dyk trods ratetal
11:16 Danske Bank om næste uges rentemøde i ECB: Stor rentenedsættelse kan komme på tale